ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research

March 8, 1991

NCI To Lose 382 Cancer FTEs; DCE Board Gets Response From Sullivan, But No Promises

July 21, 1989

Zerhouni Appoints Kington As Deputy Director

February 14, 2003

Evaluation Finds OIG Provides PIs With Flexibility

June 14, 1991

Letter to the Editor: NCI Should Continue Supporting Research In Special Populations

July 31, 1998

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979